APA-referens (7:e uppl.)

Mikaeili, B., Alqahtani, Z. A., Hincapie, A. L., & Guo, J. J. (2025). Safety of Janus kinase inhibitors in rheumatoid arthritis. Clinical Rheumatology: Journal of the International League of Associations for Rheumatology, 44(4), 1467-1474. https://doi.org/10.1007/s10067-025-07360-9

Chicago-referens (17:e uppl.)

Mikaeili, Bahar, Zuhair A. Alqahtani, Ana L. Hincapie, och Jeff Jianfei Guo. "Safety of Janus Kinase Inhibitors in Rheumatoid Arthritis." Clinical Rheumatology: Journal of the International League of Associations for Rheumatology 44, no. 4 (2025): 1467-1474. https://doi.org/10.1007/s10067-025-07360-9.

MLA-referens (9:e uppl.)

Mikaeili, Bahar, et al. "Safety of Janus Kinase Inhibitors in Rheumatoid Arthritis." Clinical Rheumatology: Journal of the International League of Associations for Rheumatology, vol. 44, no. 4, 2025, pp. 1467-1474, https://doi.org/10.1007/s10067-025-07360-9.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.